XML 16 R5.htm IDEA: XBRL DOCUMENT v3.26.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common stock and additional paid-in capital:
Accumulated deficit:
Accumulated other comprehensive income (loss):
Common stock shares:
Beginning balances at Dec. 31, 2024 $ 100,909 $ 498,840 $ (397,965) $ 34  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation   13,115      
Settlement of liability classified restricted stock units   4,996      
Issuance of common stock under stock-based compensation plans   649      
Repurchases of common stock   (15,435)      
Net income (loss) (835)   (835)    
Other comprehensive loss, net of tax       (29)  
Ending balances at Mar. 30, 2025 103,370 502,165 (398,800) 5  
Beginning balances (in shares) at Dec. 31, 2024         100,885,000
Common stock shares:          
Issuance of common stock under stock-based compensation plans (in shares)         3,817,000
Repurchase of common stock (in shares)         (1,397,000)
Ending balances (in shares) at Mar. 30, 2025         103,305,000
Beginning balances at Dec. 31, 2025 127,841 510,864 (383,039) 16  
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation   10,986      
Settlement of liability classified restricted stock units   13,848      
Issuance of common stock under stock-based compensation plans   0      
Repurchases of common stock (8,000) (8,133)      
Net income (loss) 14,877   14,877    
Other comprehensive loss, net of tax       (17)  
Ending balances at Mar. 29, 2026 $ 159,402 $ 527,565 $ (368,162) $ (1)  
Beginning balances (in shares) at Dec. 31, 2025 105,030,947       105,031,000
Common stock shares:          
Issuance of common stock under stock-based compensation plans (in shares)         4,286,000
Repurchase of common stock (in shares) (600,000)       (572,000)
Ending balances (in shares) at Mar. 29, 2026 108,745,373       108,745,000